288 related articles for article (PubMed ID: 17478000)
1. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
2. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
Moriguchi R; Kogure K; Akita H; Futaki S; Miyagishi M; Taira K; Harashima H
Int J Pharm; 2005 Sep; 301(1-2):277-85. PubMed ID: 16019173
[TBL] [Abstract][Full Text] [Related]
3. Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide.
Nakamura Y; Kogure K; Yamada Y; Futaki S; Harashima H
J Pharm Pharmacol; 2006 Apr; 58(4):431-7. PubMed ID: 16597360
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
5. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
Kogure K; Moriguchi R; Sasaki K; Ueno M; Futaki S; Harashima H
J Control Release; 2004 Aug; 98(2):317-23. PubMed ID: 15262422
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
Kogure K; Akita H; Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
[TBL] [Abstract][Full Text] [Related]
7. Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.
Sato Y; Hatakeyama H; Harashima H
Biol Pharm Bull; 2010; 33(7):1246-9. PubMed ID: 20606322
[TBL] [Abstract][Full Text] [Related]
8. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
Toriyabe N; Hayashi Y; Harashima H
Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
[TBL] [Abstract][Full Text] [Related]
9. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
10. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
11. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
12. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
14. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Kogure K; Akita H; Harashima H
Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
[TBL] [Abstract][Full Text] [Related]
15. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system.
Masuda T; Akita H; Nishio T; Niikura K; Kogure K; Ijiro K; Harashima H
Biomaterials; 2008 Feb; 29(6):709-23. PubMed ID: 18001828
[TBL] [Abstract][Full Text] [Related]
16. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging.
Kogure K; Akita H; Harashima H
J Control Release; 2007 Oct; 122(3):246-51. PubMed ID: 17651856
[TBL] [Abstract][Full Text] [Related]
18. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
19. Development of small, homogeneous pDNA particles condensed with mono-cationic detergents and encapsulated in a multifunctional envelope-type nano device.
Suzuki R; Yamada Y; Harashima H
Biol Pharm Bull; 2008 Jun; 31(6):1237-43. PubMed ID: 18520061
[TBL] [Abstract][Full Text] [Related]
20. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
